Rockefeller Capital Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
Rockefeller Capital Management's IMUX Position: Q3 2026 in Review
Rockefeller Capital Management held its Immunic (IMUX) position steady in Q3 2026 at 100 shares worth $930. The position accounts for ﹤0.01% of the portfolio, ranked #4659.
Rockefeller Capital Management first reported a position in IMUX in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.54K in Q2 2026. 79 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.
- Rockefeller Capital Management held 100 shares of Immunic worth $930 as of Q3 2026.
- Rockefeller Capital Management left its Immunic share count unchanged in Q3 2026.
- Immunic made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4659 holding.
- Rockefeller Capital Management first reported a position in Immunic in Q3 2025 and has held it in 5 quarters since.
- Rockefeller Capital Management's Immunic position peaked at $1.54K in Q2 2026.
- 79 funds tracked by Wall St. Rank held Immunic as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.